Immuno-oncology |
|
Enduring |
|
$25.00 |
Immunomodulating therapies (overview) |
|
Enduring |
|
$25.00 |
Immunopathology: evaluation, assessment, and considerations |
|
Enduring |
|
$25.00 |
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
Natural Killer Cells and their use for Cancer Immunotherapy |
|
Enduring |
|
$25.00 |
Neurotoxicity across Cancer Modalities |
|
Enduring |
|
$25.00 |
Nonclinical Safety assessment of therapies targeting neoantigens |
|
Enduring |
|
$25.00 |
Overview of Cancer Immunotherapies |
|
Enduring |
|
$35.00 |
Quantitative systems pharmacology/ toxicology modeling for IO therapies |
|
Enduring |
|
$25.00 |
Regulatory Considerations for Cancer Immunotherapies: Preclinical Focus |
|
Enduring |
|
$25.00 |
Regulatory guidance: Introduction |
|
Enduring |
|
$25.00 |
Regulatory guidance: Introduction |
|
Enduring |
|
$25.00 |
Safety assessment outside of drug development (e.g. agrichemicals, cosmetics, food additives, etc.) |
|
Enduring |
|
$25.00 |
T cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |